BioCentury
ARTICLE | Clinical News

G1T28: Phase Ib/IIa started

October 5, 2015 7:00 AM UTC

G1 began the U.S. Phase Ib/IIa 02 Study to evaluate IV G1T28 with carboplatin and etoposide in about 80 patients. All patients will receive the combination in an open-label, dose-finding part, which w...